4//SEC Filing
KYTHERA BIOPHARMACEUTICALS INC 4
Accession 0001104659-15-067089
CIK 0001436304operating
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 9:26 PM ET
Size
20.9 KB
Accession
0001104659-15-067089
Insider Transaction Report
Form 4
Klein Keith
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2015-09-23$8.22/sh+14,203$116,749→ 18,271 total - Sale
Common Stock
2015-09-23$74.90/sh−26,800$2,007,320→ 4,068 total - Exercise/Conversion
Stock Options
2015-09-23−14,203→ 0 totalExercise: $8.22Exp: 2022-02-01→ Common Stock (14,203 underlying) - Exercise/Conversion
Stock Options
2015-09-23−11,150→ 15,608 totalExercise: $44.02Exp: 2024-01-22→ Common Stock (11,150 underlying) - Exercise/Conversion
Common Stock
2015-09-23$27.50/sh+26,800$737,000→ 30,848 total - Sale
Common Stock
2015-09-23$74.90/sh−14,203$1,063,805→ 4,068 total - Exercise/Conversion
Common Stock
2015-09-23$44.02/sh+11,150$490,823→ 15,198 total - Sale
Common Stock
2015-09-23$74.90/sh−11,150$835,135→ 4,068 total - Exercise/Conversion
Stock Options
2015-09-23−13,400→ 0 totalExercise: $27.50Exp: 2023-01-29→ Common Stock (13,400 underlying)
Footnotes (2)
- [F1]The shares subject to these options vested 100% upon the achievement of certain performance milestones approved by the Issuer's Board of Directors.
- [F2]25% of the shares subject to the option vested on the first anniversary measured from January 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
KYTHERA BIOPHARMACEUTICALS INC
CIK 0001436304
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001436304
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 9:26 PM ET
- Size
- 20.9 KB